Haverford Trust Co bought a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 62,575 shares of the financial services provider’s stock, valued at approximately $13,818,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new position in CME Group during the 2nd quarter valued at approximately $6,749,965,000. Norges Bank bought a new position in CME Group during the 4th quarter worth $1,523,241,000. Bank of New York Mellon Corp bought a new position in CME Group during the 2nd quarter worth $867,313,000. Alphabet Inc. acquired a new stake in CME Group in the second quarter worth $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in CME Group in the second quarter worth $629,771,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Stock Up 1.5%
CME opened at $274.98 on Friday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $98.88 billion, a PE ratio of 23.32, a P/E/G ratio of 3.20 and a beta of 0.23. The stock’s fifty day moving average is $251.17 and its 200-day moving average is $279.65.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 44.11%.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. Piper Sandler cut their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. UBS Group cut their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Bank of America upped their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research report on Thursday, July 23rd. Weiss Ratings lowered shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, TD Cowen reduced their price objective on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $288.56.
Read Our Latest Research Report on CME
Insider Buying and Selling
In other news, Director William R. Shepard acquired 325 shares of the stock in a transaction on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.30% of the company’s stock.
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
